159 related articles for article (PubMed ID: 23954224)
1. First functional analysis of a novel splicing mutation in the B3GALTL gene by an ex vivo approach in Tunisian patients with typical Peters plus syndrome.
Ben Mahmoud A; Siala O; Mansour RB; Driss F; Baklouti-Gargouri S; Mkaouar-Rebai E; Belguith N; Fakhfakh F
Gene; 2013 Dec; 532(1):13-7. PubMed ID: 23954224
[TBL] [Abstract][Full Text] [Related]
2. Two Tunisian patients with Peters plus syndrome harbouring a novel splice site mutation in the B3GALTL gene that modulates the mRNA secondary structure.
Siala O; Belguith N; Kammoun H; Kammoun B; Hmida N; Chabchoub I; Hchicha M; Fakhfakh F
Gene; 2012 Oct; 507(1):68-73. PubMed ID: 22759511
[TBL] [Abstract][Full Text] [Related]
3. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes.
Weh E; Reis LM; Tyler RC; Bick D; Rhead WJ; Wallace S; McGregor TL; Dills SK; Chao MC; Murray JC; Semina EV
Clin Genet; 2014 Aug; 86(2):142-8. PubMed ID: 23889335
[TBL] [Abstract][Full Text] [Related]
4. Peters plus syndrome mutations affect the function and stability of human β1,3-glucosyltransferase.
Zhang A; Venkat A; Taujale R; Mull JL; Ito A; Kannan N; Haltiwanger RS
J Biol Chem; 2021 Jul; 297(1):100843. PubMed ID: 34058199
[TBL] [Abstract][Full Text] [Related]
5. Vertebral defects in patients with Peters plus syndrome and mutations in B3GALTL.
Faletra F; Athanasakis E; Minen F; Fornasier F; Marchetti F; Gasparini P
Ophthalmic Genet; 2011 Nov; 32(4):256-8. PubMed ID: 21671750
[No Abstract] [Full Text] [Related]
6. Hydrocephalus, agenesis of the corpus callosum, and cleft lip/palate represent frequent associations in fetuses with Peters' plus syndrome and B3GALTL mutations. Fetal PPS phenotypes, expanded by Dandy Walker cyst and encephalocele.
Schoner K; Kohlhase J; Müller AM; Schramm T; Plassmann M; Schmitz R; Neesen J; Wieacker P; Rehder H
Prenat Diagn; 2013 Jan; 33(1):75-80. PubMed ID: 23161355
[TBL] [Abstract][Full Text] [Related]
7. Peters plus syndrome and Chorioretinal findings associated with B3GLCT gene mutation - a case report.
Wang YE; Ramirez DA; Chang TC; Berrocal A
BMC Ophthalmol; 2020 Mar; 20(1):118. PubMed ID: 32204707
[TBL] [Abstract][Full Text] [Related]
8. Unique Presentation of Corneal Opacity in Peters Plus Syndrome: An Unusual Form of Peters Anomaly Showing Tissue Repair in Serial Analysis.
de Nie KF; Wesseling P; Eggink CA
Cornea; 2016 Feb; 35(2):277-80. PubMed ID: 26684045
[TBL] [Abstract][Full Text] [Related]
9. A novel nonsense B3GALTL mutation confirms Peters plus syndrome in a patient with multiple malformations and Peters anomaly.
Aliferis K; Marsal C; Pelletier V; Doray B; Weiss MM; Tops CM; Speeg-Schatz C; Lesnik SA; Dollfus H
Ophthalmic Genet; 2010 Dec; 31(4):205-8. PubMed ID: 21067481
[TBL] [Abstract][Full Text] [Related]
10. Contribution of a Novel
Totoń-Żurańska J; Kapusta P; Rybak-Krzyszkowska M; Lorenc K; Machlowska J; Skalniak A; Filipek E; Pawlik D; Wołkow PP
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795264
[TBL] [Abstract][Full Text] [Related]
11. Ocular Phenotype of Peters-Plus Syndrome.
Shah PR; Chauhan B; Chu CT; Kofler J; Nischal KK
Cornea; 2022 Feb; 41(2):219-223. PubMed ID: 34629439
[TBL] [Abstract][Full Text] [Related]
12. Severe Peters Plus syndrome-like phenotype with anterior eye staphyloma and hypoplastic left heart syndrome: proposal of a new syndrome.
Shimizu R; Saito R; Hoshino K; Ogawa K; Negishi T; Nishimura J; Mitsui N; Osawa M; Ohashi H
Congenit Anom (Kyoto); 2010 Sep; 50(3):197-9. PubMed ID: 20584037
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility gene card for: Peters plus syndrome.
Jaeken J; Lefeber DJ; Matthijs G
Eur J Hum Genet; 2016 Aug; 24(8):. PubMed ID: 27049305
[No Abstract] [Full Text] [Related]
14. Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism.
Vasudevan D; Takeuchi H; Johar SS; Majerus E; Haltiwanger RS
Curr Biol; 2015 Feb; 25(3):286-295. PubMed ID: 25544610
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of B3GALTL in Peters Plus syndrome.
Reis LM; Tyler RC; Abdul-Rahman O; Trapane P; Wallerstein R; Broome D; Hoffman J; Khan A; Paradiso C; Ron N; Bergner A; Semina EV
Am J Med Genet A; 2008 Oct; 146A(20):2603-10. PubMed ID: 18798333
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome.
Weh E; Takeuchi H; Muheisen S; Haltiwanger RS; Semina EV
PLoS One; 2017; 12(9):e0184903. PubMed ID: 28926587
[TBL] [Abstract][Full Text] [Related]
17. Peters Plus syndrome: a recognizable clinical entity.
Demir GÜ; Lafcı NG; Doğan ÖA; Şimşek-Kiper PÖ; Utine GE
Turk J Pediatr; 2020; 62(1):136-140. PubMed ID: 32253880
[TBL] [Abstract][Full Text] [Related]
18. Severe MDC1A congenital muscular dystrophy due to a splicing mutation in the LAMA2 gene resulting in exon skipping and significant decrease of mRNA level.
Siala O; Louhichi N; Triki C; Morinière M; Rebai A; Richard P; Guicheney P; Baklouti F; Fakhfakh F
Genet Test; 2007; 11(3):199-207. PubMed ID: 17949279
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput miRFluR Platform Identifies miRNA Regulating B3GLCT That Predict Peters' Plus Syndrome Phenotype, Supporting the miRNA Proxy Hypothesis.
Thu CT; Chung JY; Dhawan D; Vaiana CA; Mahal LK
ACS Chem Biol; 2021 Oct; 16(10):1900-1907. PubMed ID: 34085516
[TBL] [Abstract][Full Text] [Related]
20. Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase.
Lesnik Oberstein SA; Kriek M; White SJ; Kalf ME; Szuhai K; den Dunnen JT; Breuning MH; Hennekam RC
Am J Hum Genet; 2006 Sep; 79(3):562-6. PubMed ID: 16909395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
